Chen et al performed a gene polymorphism analysis in 131 patients with TAO and 227 healthy individuals, in order to test the promoters of HLA-DPB1, -DRB1 and -B, and CD14. This evidence concerns the gene CD14 and thromboangiitis obliterans.